Chemours (NYSE:CC) Stock Rating Upgraded by Mizuho

Chemours (NYSE:CCGet Free Report) was upgraded by stock analysts at Mizuho from a “neutral” rating to an “outperform” rating in a report released on Thursday, Marketbeat.com reports. The firm currently has a $19.00 price objective on the specialty chemicals company’s stock. Mizuho’s target price points to a potential upside of 38.43% from the stock’s current price.

CC has been the subject of several other reports. Morgan Stanley reduced their price target on Chemours from $25.00 to $22.00 and set an “equal weight” rating for the company in a research report on Monday, January 13th. Barclays decreased their price target on Chemours from $23.00 to $19.00 and set an “equal weight” rating on the stock in a research report on Monday, February 24th. BMO Capital Markets cut their price objective on shares of Chemours from $34.00 to $27.00 and set an “outperform” rating for the company in a research report on Wednesday, February 19th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $25.00 target price on shares of Chemours in a report on Thursday, December 12th. Finally, The Goldman Sachs Group cut their price target on shares of Chemours from $24.00 to $21.00 and set a “neutral” rating for the company in a report on Tuesday, January 7th. Four investment analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $22.89.

Get Our Latest Stock Report on Chemours

Chemours Trading Down 4.0 %

Shares of Chemours stock opened at $13.73 on Thursday. The stock has a market capitalization of $2.05 billion, a P/E ratio of 24.08 and a beta of 2.00. Chemours has a 52-week low of $13.09 and a 52-week high of $29.21. The company has a debt-to-equity ratio of 6.70, a quick ratio of 0.92 and a current ratio of 1.68. The stock’s 50-day simple moving average is $16.41 and its 200 day simple moving average is $18.19.

Chemours (NYSE:CCGet Free Report) last posted its quarterly earnings results on Tuesday, February 18th. The specialty chemicals company reported $0.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.10 by $0.01. The company had revenue of $1.36 billion for the quarter, compared to analyst estimates of $1.37 billion. Chemours had a net margin of 1.51% and a return on equity of 26.54%. As a group, research analysts anticipate that Chemours will post 2.03 EPS for the current year.

Hedge Funds Weigh In On Chemours

Several institutional investors have recently modified their holdings of the company. GAMMA Investing LLC grew its holdings in shares of Chemours by 99.7% during the 4th quarter. GAMMA Investing LLC now owns 1,532 shares of the specialty chemicals company’s stock valued at $26,000 after purchasing an additional 765 shares during the last quarter. Truvestments Capital LLC purchased a new stake in Chemours during the third quarter valued at about $35,000. Brooklyn Investment Group bought a new position in shares of Chemours during the third quarter valued at about $37,000. Quadrant Capital Group LLC increased its holdings in shares of Chemours by 100.4% in the fourth quarter. Quadrant Capital Group LLC now owns 2,234 shares of the specialty chemicals company’s stock worth $38,000 after buying an additional 1,119 shares during the period. Finally, Aster Capital Management DIFC Ltd bought a new stake in shares of Chemours in the 4th quarter valued at about $48,000. 76.26% of the stock is currently owned by institutional investors.

Chemours Company Profile

(Get Free Report)

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.

Featured Stories

Analyst Recommendations for Chemours (NYSE:CC)

Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.